since 1971 , seven randomized prospective trials and two case-control studies have been referenced in the literature or are currently being conducted , which evaluate the effects of aspirin , sulfinpyrazone , or dipyridamole in combination with aspirin in the secondary prevention of myocardial infarction .
C0038742
sulfinpyrazone
C0027051
myocardial infarction